000890421 001__ 890421
000890421 005__ 20220930130305.0
000890421 0247_ $$2doi$$a10.1016/j.nucmedbio.2020.07.003
000890421 0247_ $$2ISSN$$a0969-8051
000890421 0247_ $$2ISSN$$a1872-9614
000890421 0247_ $$2Handle$$a2128/27212
000890421 0247_ $$2pmid$$a32900582
000890421 0247_ $$2WOS$$aWOS:000616652500023
000890421 037__ $$aFZJ-2021-00941
000890421 041__ $$aEnglish
000890421 082__ $$a570
000890421 1001_ $$0P:(DE-Juel1)131816$$aCoenen, Heinrich Hubert$$b0$$ufzj
000890421 245__ $$aExpanding PET-applications in life sciences with positron-emitters beyond fluorine-18
000890421 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2021
000890421 3367_ $$2DRIVER$$aarticle
000890421 3367_ $$2DataCite$$aOutput Types/Journal article
000890421 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1614866615_2428
000890421 3367_ $$2BibTeX$$aARTICLE
000890421 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000890421 3367_ $$00$$2EndNote$$aJournal Article
000890421 520__ $$aPositron emission tomography (PET) has become an indispensable diagnostic tool in modern nuclear medical diagnostics. Its outstanding molecular imaging features allow repetitive studies on one individual and with high sensitivity, though no interference. Rather few positron emitters with near favourable physical properties, i.e. carbon-11 and fluorine-18, furnished most studies in the beginning, preferably if covalently bound as isotopic label of small molecules. With the advancement of PET-devices the scope of in vivo research in life sciences and especially that of medical applications expanded, and other than “standard” PET-nuclides received increasing significance, like the radiometals copper-64 and gallium-68. Especially during the last decades, positron emitters of other chemical elements have gotten into the focus of interest, concomitant with the technical advancements in imaging and radionuclide production. With known nuclear imaging properties and main production methods of emerging positron emitters their usefulness for medical application is promising and even proven for several ones already. Unfortunate decay properties could be corrected for, and β+-emitters, especially with a longer half-life, provided new possibilities for application where slower processes are of importance.Further on, (bio)chemical features of positron emitters of other elements, among there many metals, not only expanded the field of classical clinical investigations, but also opened up new fields of application. Appropriately labelled peptides, proteins and nanoparticles lend itself as newer probes for PET-imaging, e.g. in theragnostic or PET/MR hybrid imaging. Furthermore, the potential of non-destructive in-vivo imaging with positron emission tomography directs the view on further areas of life sciences. Thus, exploiting the excellent methodology for basic research on molecular biochemical functions and processes is increasingly encouraged as well in areas outside of health, such as plant and environmental sciences.
000890421 536__ $$0G:(DE-HGF)POF4-525$$a525 - Decoding Brain Organization and Dysfunction (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000890421 588__ $$aDataset connected to CrossRef
000890421 7001_ $$0P:(DE-Juel1)131818$$aErmert, Johannes$$b1$$eCorresponding author
000890421 770__ $$aA Special Issue dedicated to Professor Bill Eckelman, Editor-in-Chief of NMB 1985 to 2017
000890421 773__ $$0PERI:(DE-600)1498538-x$$a10.1016/j.nucmedbio.2020.07.003$$gp. S096980512030192X$$p241–269$$tNuclear medicine and biology$$v92$$x0969-8051$$y2021
000890421 8564_ $$uhttps://juser.fz-juelich.de/record/890421/files/19962CV6-1.pdf
000890421 8564_ $$uhttps://juser.fz-juelich.de/record/890421/files/1-s2.0-S096980512030192X-main.pdf$$yRestricted
000890421 8564_ $$uhttps://juser.fz-juelich.de/record/890421/files/Expanding%20PET-applications%20final.pdf$$yPublished on 2020-07-17. Available in OpenAccess from 2021-07-17.
000890421 8767_ $$819962CV6$$92021-02-22$$d2021-02-24$$eColour charges$$jZahlung erfolgt$$z400USD / Belegnr. 1200164243
000890421 909CO $$ooai:juser.fz-juelich.de:890421$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000890421 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131816$$aForschungszentrum Jülich$$b0$$kFZJ
000890421 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich$$b1$$kFZJ
000890421 9130_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000890421 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000890421 9141_ $$y2021
000890421 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-10-12
000890421 915__ $$0LIC:(DE-HGF)CCBYNCND4$$2HGFVOC$$aCreative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0
000890421 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000890421 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNUCL MED BIOL : 2018$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-10-12
000890421 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-10-12$$wger
000890421 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-10-12
000890421 920__ $$lyes
000890421 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000890421 980__ $$ajournal
000890421 980__ $$aVDB
000890421 980__ $$aI:(DE-Juel1)INM-5-20090406
000890421 980__ $$aAPC
000890421 980__ $$aUNRESTRICTED
000890421 9801_ $$aAPC
000890421 9801_ $$aFullTexts